Sandrine Jayne

7PUBLICATIONS
13CO-AUTHORS
Liquid biopsiesHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 03, 2025
In vitro comparison of CD20xCD3 bispecific antibodies against diffuse large B-cell lymphoma (DLBCL) cell lines with different levels of expression of CD20.

Joshua S Bray, Gethin R Thomas, Victoria M Smith

|Dec 27, 2024
Impact of the clinically approved BTK inhibitors on the conformation of full-length BTK and analysis of the development of BTK resistance mutations in chronic lymphocytic leukemia.

Raji E Joseph, Thomas E Wales, Sandrine Jayne

|Oct 15, 2024
The chromosomal translocation t(1;6)(p35.3;p25.2), recurrent in chronic lymphocytic leukaemia, leads to RCC1::IRF4 fusion.

Sandrine Jayne, Cristina López, Natalie Put

|Aug 19, 2024
Monitoring of molecular responses to tirabrutinib in a cohort of exceptional responders with relapsed/refractory mantle cell lymphoma.

Abdullah N M Alqahtani, Sandrine Jayne, Matthew J Ahearne

|Jan 08, 2024
Impact of the clinically approved BTK inhibitors on the conformation of full-length BTK and analysis of the development of BTK resistance mutations in chronic lymphocytic leukemia.

Raji E Joseph, Thomas E Wales, Sandrine Jayne

|Apr 06, 2017
Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.

Harriet S Walter, Sandrine Jayne, Simon A Rule

Pageof 2

Frequent Collaborators

5 joint publications

Martin J S Dyer

4 joint publications

Harriet S Walter

2 joint publications

Thomas E Wales

2 joint publications

John R Engen